Detalhe da pesquisa
1.
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Nature
; 555(7698): 673-677, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562231
2.
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance.
Cell Rep
; 39(12): 111015, 2022 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732117
3.
Targeting Soluble DPP-4 for Insulin Resistance: Origin Matters.
J Clin Endocrinol Metab
; 106(3): e1460-e1462, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274386
4.
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance.
Cell Rep
; 15(10): 2214-2225, 2016 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27239042
5.
Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.
Diabetes
; 64(10): 3396-405, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26068544